Skip to content
Wenlo
Sign in
← Markets

Hilton Worldwide Holdings Inc.

Kevin J Jacobs (See Remarks) sells HLT shares

4HLTFiled Oct 30, 2026, 4:33 PM ET· Period Oct 29, 2026

Summary from the key facts

Kevin J Jacobs (See Remarks) at Hilton Worldwide Holdings Inc. sold 151,050 shares at an average $356.19 (≈$53.8M) and acquired 151,050 shares by exercising or converting derivatives on Oct 29, 2026. Kevin J Jacobs held 293,758 shares directly after the last reported transaction.

Key facts

Insider
Kevin J Jacobs · See Remarks
DateTransactionSharesPriceValueHeld afterOwnership
Oct 29, 2026M · exercise or conversion of a derivative+12,848$83.10$1,067,668.80306,606Direct
Oct 29, 2026M · exercise or conversion of a derivative+29,110$93.33$2,716,836.30335,716Direct
Oct 29, 2026M · exercise or conversion of a derivative+28,538$123.13$3,513,883.94364,254Direct
Oct 29, 2026M · exercise or conversion of a derivative+27,370$150.67$4,123,837.90391,624Direct
Oct 29, 2026M · exercise or conversion of a derivative+31,058$146.19$4,540,369.02422,682Direct
Oct 29, 2026M · exercise or conversion of a derivative+15,999$203.96$3,263,156.04438,681Direct
Oct 29, 2026M · exercise or conversion of a derivative+6,127$259.10$1,587,505.70444,808Direct
Oct 29, 2026S · open-market saleFootnotes F1−7,864$353.18$2,777,368.20436,944Direct
Oct 29, 2026S · open-market saleFootnotes F2−21,895$354.19$7,755,033.84415,049Direct
Oct 29, 2026S · open-market saleFootnotes F3−38,108$355.06$13,530,588.37376,941Direct
Oct 29, 2026S · open-market saleFootnotes F4−10,667$355.99$3,797,292.00366,274Direct
Oct 29, 2026S · open-market saleFootnotes F5−28,531$357.24$10,192,271.79337,743Direct
Oct 29, 2026S · open-market saleFootnotes F6−42,794$358.05$15,322,562.88294,949Direct
Oct 29, 2026S · open-market saleFootnotes F7−1,191$358.79$427,317.70293,758Direct
Oct 29, 2026M · exercise or conversion of a derivativeEmployee Stock Option (right to buy)Footnotes F9−12,848$0.00$0.000Direct
Oct 29, 2026M · exercise or conversion of a derivativeEmployee Stock Option (right to buy)Footnotes F10−29,110$0.00$0.000Direct
Oct 29, 2026M · exercise or conversion of a derivativeEmployee Stock Option (right to buy)Footnotes F11−28,538$0.00$0.000Direct
Oct 29, 2026M · exercise or conversion of a derivativeEmployee Stock Option (right to buy)Footnotes F12−27,370$0.00$0.000Direct
Oct 29, 2026M · exercise or conversion of a derivativeEmployee Stock Option (right to buy)Footnotes F13−31,058$0.00$0.000Direct
Oct 29, 2026M · exercise or conversion of a derivativeEmployee Stock Option (right to buy)Footnotes F14−15,999$0.00$0.008,001Direct
Oct 29, 2026M · exercise or conversion of a derivativeEmployee Stock Option (right to buy)Footnotes F15−6,127$0.00$0.0012,256Direct
Footnotes
  1. F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $352.555 to $353.555, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  2. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $353.58 to $354.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  3. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $354.595 to $355.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  4. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $355.60 to $356.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  5. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $356.65 to $357.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  6. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $357.66 to $358.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  7. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $358.675 to $359.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  8. F8 Reflects indirect ownership by a family trust for which the reporting person's spouse serves as trustee.
  9. F9 The option vested in three equal annual installments beginning on March 3, 2020.
  10. F10 The option vested in three equal annual installments beginning on March 3, 2021.
  11. F11 The option vested in three equal annual installments beginning on March 3, 2022.
  12. F12 The option vested in three equal annual installments beginning on March 3, 2023.
  13. F13 The option vested in three equal annual installments beginning on March 3, 2024.
  14. F14 The option vests in three equal annual installments beginning on March 3, 2025.
  15. F15 The option vests in three equal annual installments beginning on March 3, 2026.

Remarks: Executive Vice President and Chief Financial Officer

More HLT filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.